Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level
- PMID: 2441737
- DOI: 10.1111/j.1471-0528.1987.tb03167.x
Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level
Abstract
On the basis of the significantly different distributions of maternal serum alpha-fetoprotein (AFP) levels in 86 pregnancies associated with fetal Down's syndrome and in 2018 unaffected pregnancies, an iso-risk curve for Down's syndrome was constructed. An iso-risk curve shows, for women of all ages, which combinations of maternal age and level of maternal serum AFP result in the same risk of carrying a fetus with Down's syndrome. A 1:400 risk of Down's syndrome, corresponding to the risk of a 35-year-old woman, was chosen as the lowest risk indicating referral for amniocentesis. If all women, irrespective of their age, are offered amniocentesis, when their risk of carrying a Down's syndrome fetus is 1:400 or higher, 53% of the affected fetuses can be detected as compared with 28% of the affected fetuses diagnosed at present in women above 35 years of age.
Similar articles
-
Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.N Engl J Med. 1987 Aug 6;317(6):342-6. doi: 10.1056/NEJM198708063170603. N Engl J Med. 1987. PMID: 2439909
-
Prenatal screening for Down's syndrome with use of maternal serum markers.N Engl J Med. 1992 Aug 27;327(9):588-93. doi: 10.1056/NEJM199208273270902. N Engl J Med. 1992. PMID: 1379344
-
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.N Engl J Med. 1994 Apr 21;330(16):1114-8. doi: 10.1056/NEJM199404213301603. N Engl J Med. 1994. PMID: 7510852
-
Antenatal screening for Down's syndrome.J Med Screen. 1997;4(4):181-246. doi: 10.1177/096914139700400402. J Med Screen. 1997. PMID: 9494915 Review.
-
Prenatal biochemical screening for Down's syndrome and neural tube defects.Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7. Curr Opin Obstet Gynecol. 1992. PMID: 1373963 Review.
Cited by
-
Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome.Hum Genet. 1990 Aug;85(3):362-6. doi: 10.1007/BF00206762. Hum Genet. 1990. PMID: 2144256
-
Variability in predicted rates of Down syndrome associated with elevated maternal serum alpha-fetoprotein levels in older women.Am J Hum Genet. 1988 Aug;43(2):160-4. Am J Hum Genet. 1988. PMID: 2456690 Free PMC article.
-
Screening for Down syndrome.Am J Hum Genet. 1989 Apr;44(4):586-90. Am J Hum Genet. 1989. PMID: 2467558 Free PMC article. No abstract available.
-
Second trimester serum tests for Down's Syndrome screening.Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925. Cochrane Database Syst Rev. 2012. PMID: 22696388 Free PMC article.
-
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012600. doi: 10.1002/14651858.CD012600. Cochrane Database Syst Rev. 2017. PMID: 28295158 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical